Loading viewer...
report
Format: PDF report
This report details the development and clinical evaluation of BIO89-100, a novel FGF21 analog for treating NASH and severe hypertriglyceridemia.
presentation
report
Cliffs Natural Resources
report
Devmountain
report
Reliance Jio Infocomm Limited
report
1st Source Corporation